New data shows New York’s minimal spending of opioid settlement funds

Recent data reveals that New York State has utilized only a small portion of the funds acquired through opioid settlement agreements. Despite numerous lawsuits against pharmaceutical companies, the state’s expenditure on programs designed to combat the opioid crisis remains minimal. The funds, intended for treatment and prevention services, have largely remained untapped, raising concerns about the urgency of addressing the escalating opioid epidemic. Public health experts advocate that these crucial funds should be utilized promptly to maximize their impact on recovery and prevention efforts. Transparency in how these funds are allocated is also a focal point for advocacy groups. The slow disbursement of resources has sparked debate on government accountability and efficiency in managing settlement funds.

Crain’s New York Business